Bellevue Asset Management »

Teva Pharmaceutical Industries shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2015-12-31 $12M 177k 65.64
2015-09-30 $9.6M 169k 56.46
2015-06-30 $9.9M 167k 59.10
2015-03-31 $8.7M 140k 62.30

More positions owned by Bellevue Asset Management

Celgene Corporation
Biogen Idec (BIIB)
Gilead Sciences (GILD)
Amgen (AMGN)
Regeneron Pharmaceuticals (REGN)
Medtronic
Illumina (ILMN)
Abbott Laboratories (ABT)
Mylan
Becton, Dickinson and (BDX)
Cardinal Health (CAH)
UnitedHealth (UNH)
Stryker Corporation (SYK)
Teva Pharmaceutical Industries (TEVA)
Express Scripts Holding

View all positions for Bellevue Asset Management

Top funds holding Teva Pharmaceutical Industries

BlackRock
BlackRock
Ion Asset Management
Clal Insurance Enterprises Holdings
Exor Investments
Migdal Insurance & Financial Holdings
Phoenix Holdings
State Street Corporation
Rubric Capital Management
Arrowstreet Capital, Limited Partnership
Slate Path Capital
Morgan Stanley
PointState Capital
Geode Capital Management
Glenview Captal Management

View all funds holding Teva Pharmaceutical Industries